Cetuximab for colorectal cancer.
van der Spek
Ellen
E
Sonke
Gabe S
GS
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D018572:Disease-Free Survival; D066246:ErbB Receptors / Q000276:immunology*; D006801:Humans; D053208:Kaplan-Meier Estimate; D016016:Proportional Hazards Models
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D066246:ErbB Receptors; D000068818:Cetuximab